What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock used to aggregate holder disclosures.

How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in Q2 2023?

155 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock for Q2 2023. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)

CUSIP: 75629V104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Class A Stock
Shares outstanding: 525,302,736
Total 13F shares: 127,547,789
Share change: +1,393,964
Total reported value: $952,749,699
Put/Call ratio: 96%
Price per share: $7.47
Number of holders: 155
Value change: +$12,757,431
Number of buys: 81
Number of sells: 69

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 75629V104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAILLIE GIFFORD & CO	13F	Company	— mixed-class rows	268,003,790 mixed-class rows	$490,668,771	—	31 Mar 2023	13F
ARK Investment Management LLC	13F	Company	— mixed-class rows	168,333,847 mixed-class rows	$242,984,460	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	— mixed-class rows	121,824,917 mixed-class rows	$220,412,478	—	31 Mar 2023	13F
VIKING GLOBAL INVESTORS LP	13F	Company	37%	143,085,126	$190,303,218	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	— mixed-class rows	61,295,937 mixed-class rows	$138,297,713	—	31 Mar 2023	13F
Lux Ventures IV, L.P.	3/4/5	Former 10% Owner	— class O/S missing	13,021,519	$137,710,376	—	07 Dec 2021	3/4/5
Mubadala Investment Co PJSC	3/4/5	10%+ Owner	— class O/S missing	12,985,927	$137,333,970	—	02 Mar 2023	3/4/5
Anchorage Capital Group, L.L.C.	13F	Company	18%	69,854,593	$92,906,609	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	— mixed-class rows	59,299,786 mixed-class rows	$80,253,734	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	— mixed-class rows	21,080,023 mixed-class rows	$62,064,784	—	31 Mar 2023	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	— mixed-class rows	43,098,572 mixed-class rows	$60,001,658	—	31 Mar 2023	13F
Amova Asset Management Americas, Inc.	13F	Company	— mixed-class rows	43,098,572 mixed-class rows	$59,099,528	—	31 Mar 2023	13F
MIC Capital Management UK LLP	13F	Company	1.6%	8,451,758	$56,373,229	—	31 Mar 2023	13F
Kinnevik AB (publ)	13F	Company	1.5%	7,653,061	$51,045,917	—	31 Mar 2023	13F
GENERAL ATLANTIC, L.P.	13F	Individual	8.4%	32,319,896	$42,985,462	—	31 Mar 2023	13F
Data Collective IV GP, LLC	13F	Company	1.1%	5,941,120	$39,627,270	—	31 Mar 2023	13F
NORGES BANK	13F	Company	— mixed-class rows	10,580,689 mixed-class rows	$36,639,616	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— mixed-class rows	16,429,880 mixed-class rows	$36,501,961	—	31 Mar 2023	13F
FMR LLC	13F	Company	— mixed-class rows	6,381,275 mixed-class rows	$33,881,256	—	31 Mar 2023	13F
SB INVESTMENT ADVISERS (UK) LTD	13F	Company	6.4%	24,429,191	$32,490,824	—	31 Mar 2023	13F
Laurion Capital Management LP	13F	Company	0.92%	4,825,735	$32,187,653	—	31 Mar 2023	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.53%	2,770,451	$18,478,908	—	31 Mar 2023	13F
MIC Capital Partners (Public) Parallel Cayman, LP	3/4/5	10%+ Owner	— class O/S missing	1,388,889	$14,688,335	—	01 Nov 2021	3/4/5
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— mixed-class rows	6,333,759 mixed-class rows	$13,678,134	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	— mixed-class rows	5,568,017 mixed-class rows	$13,577,312	—	31 Mar 2023	13F
MV Management XI, L.L.C.	13F	Company	0.38%	1,971,908	$13,152,626	—	31 Mar 2023	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	— mixed-class rows	8,727,956 mixed-class rows	$12,312,009	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	— mixed-class rows	2,741,559 mixed-class rows	$12,096,147	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	— mixed-class rows	3,937,964 mixed-class rows	$10,713,000	—	31 Mar 2023	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.29%	1,509,254	$10,066,724	—	31 Mar 2023	13F
Duquesne Family Office LLC	13F	Company	0.26%	1,385,950	$9,259,000	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.8%	6,763,008	$8,994,801	—	31 Mar 2023	13F
Erste Asset Management GmbH	13F	Company	— mixed-class rows	6,441,264 mixed-class rows	$8,738,401	—	31 Mar 2023	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	— mixed-class rows	5,087,840 mixed-class rows	$8,728,690	—	31 Mar 2023	13F
Comprehensive Financial Management LLC	13F	Company	— mixed-class rows	1,815,697 mixed-class rows	$8,339,047	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	— mixed-class rows	3,799,708 mixed-class rows	$7,879,309	—	31 Mar 2023	13F
ArchPoint Investors	13F	Company	— mixed-class rows	1,145,834 mixed-class rows	$7,476,062	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	— mixed-class rows	3,073,813 mixed-class rows	$7,062,604	—	31 Mar 2023	13F
Cercano Management LLC	13F	Company	0.19%	978,051	$6,523,600	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	— mixed-class rows	1,496,958 mixed-class rows	$5,666,076	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	— mixed-class rows	1,523,928 mixed-class rows	$5,260,274	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	— mixed-class rows	3,563,664 mixed-class rows	$5,140,000	—	31 Mar 2023	13F
EQUITEC PROPRIETARY MARKETS, LLC	13F	Company	0.95%	3,645,650	$4,848,715	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— mixed-class rows	2,781,956 mixed-class rows	$4,791,513	—	31 Mar 2023	13F
ALLEN OPERATIONS LLC	13F	Company	— mixed-class rows	2,695,755 mixed-class rows	$4,747,643	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.13%	697,285	$4,650,891	—	31 Mar 2023	13F
Ensign Peak Advisors, Inc	13F	Company	0.9%	3,443,429	$4,579,761	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.12%	646,610	$4,313,000	—	31 Mar 2023	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.84%	3,201,699	$4,258,260	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	— mixed-class rows	764,046 mixed-class rows	$3,873,759	—	31 Mar 2023	13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) as of Q2 2023

As of 30 Jun 2023, RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX) was held by 155 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 127,547,789 shares. The largest 10 holders included BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Kinnevik AB (publ), MIC Capital Management UK LLP, Data Collective IV GP, LLC, STATE STREET CORP, ARK Investment Management LLC, FMR LLC, and Laurion Capital Management LP. This page lists 155 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

157

Q2 2023 holders

155

Holder diff

-2

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.